Jing Fu

Jing Fu

Auto-generated profile, based on publicly available information

Jing Fu

Department of Biochemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, People’s Republic of China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2016 in Biotechnology for Biofuels
Verified
Journal Article
Open access
PDF file
JFJing Fu
Jing Fu
GHGuangxin Huo
Guangxin Huo
LFLili Feng
Lili Feng
YMYufeng Mao
Yufeng Mao
Zhiwen WangZhiwen Wang
Zhiwen Wang
XZXueming Zhao
Xueming Zhao
2,3-Butanediol (2,3-BD) with low toxicity to microbes, could be a promising alternative for biofuel production. However, most of the 2,3-BD producers are opportunistic pathogens that are not suitable for industrial-scale fermentation. In our previous study, wild-type Bacillus subtilis 168, as a class I microorganism, was first found to generate only d-(−)-2,3-BD (purity >99 %) under low oxygen conditions. In this work, B. subtilis was engineered to produce chiral pure meso-2,3-BD. First, d-(−)-2,3-BD production was abolished by deleting d-(−)-2,3-BD dehydrogenase coding gene bdhA, and acoA gene was knocked out to prevent the degradation of acetoin (AC), the immediate precursor of 2,3-BD. Next, both pta and ldh gene were deleted to decrease the accumulation of the byproducts, acetate and l-lactate. We further introduced the meso-2,3-BD dehydrogenase coding gene budC from Klebsiella pneumoniae CICC10011, as well as overexpressed alsSD in the tetra-mutant (ΔacoAΔbdhAΔptaΔldh) to achieve the efficient production of chiral meso-2,3-BD. Finally, the pool of NADH availability was further increased to facilitate the conversion of meso-2,3-BD from AC by overexpressing udhA gene (coding a soluble transhydrogenase) and low dissolved oxygen control during the cultivation. Under microaerobic oxygen conditions, the best strain BSF9 produced 103.7 g/L meso-2,3-BD with a yield of 0.487 g/g glucose in the 5-L batch fermenter, and the titer of the main byproduct AC was no more than 1.1 g/L. This work offered a novel strategy for the production of chiral pure meso-2,3-BD in B. subtilis. To our knowledge, this is the first report indicating that metabolic engineered B. subtilis could produce chiral meso-2,3-BD with high purity under limited oxygen conditions. These results further demonstrated that B. subtilis as a class I microorganism is a competitive industrial-level meso-2,3-BD producer.

30 November 2015 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
LFLili Feng
Lili Feng
YZYa Zhang
Ya Zhang
JFJing Fu
Jing Fu
YMYufeng Mao
Yufeng Mao
TCTao Chen
Tao Chen
Zhiwen WangZhiwen Wang
Zhiwen Wang

2 May 2014 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
JFJing Fu
Jing Fu
ZWZhiwen Wang
Zhiwen Wang
TCTao Chen
Tao Chen
WLWeixi Liu
Weixi Liu
TSTing Shi
Ting Shi
XZXueming Zhao
Xueming Zhao

15 July 2014 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
TSTing Shi
Ting Shi
YWYongcheng Wang
Yongcheng Wang
Zhiwen WangZhiwen Wang
Zhiwen Wang
GWGuanglu Wang
Guanglu Wang
DLDingyu Liu
Dingyu Liu
XZXueming Zhao
Xueming Zhao
Purine nucleotides are essential metabolites for living organisms because they are involved in many important processes, such as nucleic acid synthesis, energy supply, and biosynthesis of several amino acids and riboflavin. Owing to the pivotal roles of purines in cell physiology, the pool of intracellular purine nucleotides must be maintained under strict control, and hence the de novo purine biosynthetic pathway is tightly regulated by transcription repression and inhibition mechanism. Deregulation of purine pathway is essential for this pathway engineering in Bacillus subtilis. Deregulation of purine pathway was attempted to improve purine nucleotides supply, based on a riboflavin producer B. subtilis strain with modification of its rib operon. To eliminate transcription repression, the pur operon repressor PurR and the 5’-UTR of pur operon containing a guanine-sensing riboswitch were disrupted. Quantitative RT-PCR analysis revealed that the relative transcription levels of purine genes were up-regulated about 380 times. Furthermore, site-directed mutagenesis was successfully introduced into PRPP amidotransferase (encoded by purF) to remove feedback inhibition by homologous alignment and analysis. Overexpression of the novel mutant PurF (D293V, K316Q and S400W) significantly increased PRPP amidotransferase activity and triggered a strong refractory effect on purine nucleotides mediated inhibition. Intracellular metabolite target analysis indicated that the purine nucleotides supply in engineered strains was facilitated by a stepwise gene-targeted deregulation. With these genetic manipulations, we managed to enhance the metabolic flow through purine pathway and consequently increased riboflavin production 3-fold (826.52 mg/L) in the purF-VQW mutant strain. A sequential optimization strategy was applied to deregulate the rib operon and purine pathway of B. subtilis to create genetic diversities and to improve riboflavin production. Based on the deregulation of purine pathway at transcription and metabolic levels, an extended application is recommended for the yield of products, like inosine, guanosine, adenosine and folate which are directly stemming from purine pathway in B. subtilis.

1 July 2018 in Metabolic Engineering
Verified
Journal Article
Closed access
GWGuanglu Wang
Guanglu Wang
TSTing Shi
Ting Shi
TCTao Chen
Tao Chen
XWXiaoyue Wang
Xiaoyue Wang
YWYongcheng Wang
Yongcheng Wang
XZXueming Zhao
Xueming Zhao

20 June 2012 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
MWMeng Wang
Meng Wang
JFJing Fu
Jing Fu
XZXueyu Zhang
Xueyu Zhang
TCTao Chen
Tao Chen